Massachusetts data show a decline in cases and hospitalizations, which is good news. But it is not a precipitous decrease, judging from the still elevated test positivity – 7.72% – and hospitalizations (696). We’re on the mend, so to speak, but with 28 deaths reported today and still dozens of folks intubated and in ICU with hundreds more hospitalized, it’s not yet time to celebrate. In Massachusetts, we have a 5 to 6 times greater caseload than last year at this time.
Thanks TK.
Massachusetts data show a decline in cases and hospitalizations, which is good news. But it is not a precipitous decrease, judging from the still elevated test positivity – 7.72% – and hospitalizations (696). We’re on the mend, so to speak, but with 28 deaths reported today and still dozens of folks intubated and in ICU with hundreds more hospitalized, it’s not yet time to celebrate. In Massachusetts, we have a 5 to 6 times greater caseload than last year at this time.
You may be interested in my latest Forbes piece. I wrote about the Pfizer initiative to sell its patented products to low-income countries on a not-for-profit basis. https://www.forbes.com/sites/joshuacohen/2022/06/01/pfizers-not-for-profit-model-for-sales-of-products-to-lowand-lower-middle-income-countries-may-be-a-game-changer-in-global-health/
C-19 / 6-2 / ready